DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
174 hedge funds and large institutions have $547M invested in DIPLOMAT PHARMACY, INC. in 2016 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 60 increasing their positions, 54 reducing their positions, and 46 closing their positions.
278% more call options, than puts
Call options by funds: $665K | Put options by funds: $176K
11% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 54
6% less funds holding
Funds holding: 185 → 174 (-11)
17% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 46
62% less capital invested
Capital invested by funds: $1.44B → $547M (-$891M)
Top Buyers
Top Sellers
| 1 |
Wells Fargo
San Francisco,
California
|
-$44.8M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$43.7M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$36M |
| 4 |
BAMCO Inc
New York
|
-$35.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$35.6M |
DPLO Hedge Fund Activity: Q4 2016 in Review
174 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2016, worth a combined $547M — down 62% from $1.44B a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of DPLO and 38 opened new positions — a net loss of 8 holders — while 54 trimmed existing stakes and 60 added.
The largest buyer was Millennium Management, adding an estimated $14.5M. The largest seller was Wells Fargo, cutting an estimated $44.8M.
- 174 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2016, down from 185 in Q3 2016.
- Funds reported $547M of DIPLOMAT PHARMACY, INC. stock for Q4 2016, down 62% quarter-over-quarter.
- 38 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2016 and 46 closed out, a net change of -8 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2016 was Millennium Management, an estimated $14.5M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q4 2016 was Wells Fargo, an estimated $44.8M sold.
Based on aggregated 13F filings for Q4 2016.